Oxygen concentration influences mRNA processing and expression of the cd34 gene

CD34 is a cell surface glycoprotein expressed on hematopoietic stem and progenitor cells that disappears with their maturation. This gene is transcribed in two alternatively spliced mRNAs that encode full length and truncated form of CD34 cell surface antigen. Some publications suggested that CD34 full length plays a role in the maintenance of their self renewal capacity. An examination of CD34 regulation by a low O2 concentration that ensures a better maintenance of stem cells may provide important insights into the molecular control of hematopoiesis. Using human cord blood CD34+ cells, we first compared the effect of short term (24 h) culture in hypoxia (1% O2) and normoxia (20% O2) on the expression of full length and truncated form of cd34 transcripts and on the expression of the CD34 antigen. Hypoxia maintained a larger quantity of cd34 full length transcripts and a higher cd34 full length/cd34 truncated form ratio than normoxia. After 72 h of culture at 1% and 20% O2, sorted CD34low sub‐population from 1% O2 primary culture still contained more cd34 full length mRNAs than those from 20% O2, maintained better CD34 antigen expression during secondary culture at 20% O2 and contained more undifferentiated cells. This work provides the first evidence of the regulation of the cd34 gene by hypoxia resulting in a delayed higher and longer antigen expression by cord blood cells. We suggest that this phenomenon is related to the better maintenance of primitive stem cells in hypoxia. J. Cell. Biochem. © 2005 Wiley‐Liss, Inc.

[1]  F. Lacombe,et al.  Simultaneous Maintenance of Human Cord Blood SCID‐Repopulating Cells and Expansion of Committed Progenitors at Low O2 Concentration (3%) , 2004, Stem cells.

[2]  P. Ratcliffe,et al.  HIF prolyl and asparaginyl hydroxylases in the biological response to intracellular O2 levels , 2003, Journal of Cell Science.

[3]  M. Simon,et al.  Expansion of human SCID-repopulating cells under hypoxic conditions. , 2003, The Journal of clinical investigation.

[4]  M. Ogawa,et al.  Reversible expression of CD34 by adult human bone marrow long-term engrafting hematopoietic stem cells. , 2003, Experimental hematology.

[5]  G. Seitz,et al.  Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells. , 2003, Blood.

[6]  S. Rutella,et al.  Transforming growth factor‐β1 causes transcriptional activation of CD34 and preserves haematopoietic stem/progenitor cell activity , 2002, British journal of haematology.

[7]  Seng H. Cheng,et al.  Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. , 2002, Biochemical and biophysical research communications.

[8]  K. Shirato,et al.  Hypoxia induces transcription factor ETS-1 via the activity of hypoxia-inducible factor-1. , 2001, Biochemical and biophysical research communications.

[9]  W M Miller,et al.  Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. , 2001, Biophysical journal.

[10]  C. Barthe,et al.  Expression of interferon-alpha (IFN-alpha) receptor 2c at diagnosis is associated with cytogenetic response in IFN-alpha-treated chronic myeloid leukemia. , 2001, Blood.

[11]  M. Ogawa,et al.  Reciprocal expression of CD38 and CD34 by adult murine hematopoietic stem cells. , 2001, Blood.

[12]  V. Praloran,et al.  Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent , 2000, Transfusion.

[13]  V. Praloran,et al.  Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors. , 2000, Blood cells, molecules & diseases.

[14]  M. Ogawa.  Changing phenotypes of hematopoietic stem cells. , 2000, Experimental hematology.

[15]  Bartolozzi,et al.  Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow‐repopulating ability together with the expansion of committed progenitors , 2000, British journal of haematology.

[16]  N. Fortunel,et al.  TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. , 2000, Journal of cell science.

[17]  M. Ogawa,et al.  Reversible expression of CD34 by murine hematopoietic stem cells. , 1999, Blood.

[18]  J. Reiffers,et al.  Endothelial cell support of hematopoiesis is differentially altered by IL-1 and glucocorticoids , 1998, Leukemia.

[19]  B. Beckman,et al.  Post-transcriptional Regulation of Erythropoietin mRNA Stability by Erythropoietin mRNA-binding Protein* , 1997, The Journal of Biological Chemistry.

[20]  J. Gleadle,et al.  Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. , 1997, Blood.

[21]  G. Semenza,et al.  Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1* , 1996, The Journal of Biological Chemistry.

[22]  A. Shyu,et al.  Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: evidence for a novel class of AU-rich elements , 1996, Molecular and cellular biology.

[23]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Fackler,et al.  Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. , 1995, Blood.

[25]  M. Greaves,et al.  CD34 expression is regulated reciprocally with adhesion molecules in vascular endothelial cells in vitro. , 1993, Blood.

[26]  H. Nakauchi,et al.  Two alternative forms of cDNA encoding CD34. , 1993, Experimental hematology.

[27]  M. Fackler,et al.  Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34. , 1992, The Journal of biological chemistry.

[28]  B. Davis,et al.  Isolation and molecular characterization of the human CD34 gene. , 1992, Blood.

[29]  S. Antonarakis,et al.  Hypoxia-inducible nuclear factors bind to an enhancer element located 3' to the human erythropoietin gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[31]  V. Praloran,et al.  Hypoxia maintains and interleukin-3 reduces the pre-colony-forming cell potential of dividing CD34(+) murine bone marrow cells. , 2002, Experimental hematology.

[32]  M. Fackler,et al.  CD34: structure, biology, and clinical utility. , 1996, Blood.

[33]  O. Majdic,et al.  Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. , 1994, Blood.